middle.news
PolyNovo’s FY25 Sales Soar 29% as FDA Clears Key Wound Care Products
10:46pm on Friday 29th of August, 2025 AEST
•
Healthcare
Read Story
PolyNovo’s FY25 Sales Soar 29% as FDA Clears Key Wound Care Products
10:46pm on Friday 29th of August, 2025 AEST
Key Points
Group sales up 28.9% to A$118.6 million
Net profit after tax rises 151.2% to A$13.2 million
Strong U.S. sales growth of 28.7% to A$88.4 million
FDA clearances expanded for NovoSorb BTM and MTX products
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Polynovo (ASX:PNV)
OPEN ARTICLE